Latest in Moderna Pfizer
Sort by
13 items
-
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the ...Business - MarketWatch - 11 hours ago -
Starboard calls for Pfizer board to ‘hold management accountable’
Jeff Smith tells activist investor conference that pharma group’s recent returns are ‘not adequate’Business - Financial Times - October 22 -
Pfizer’s earnings crush estimates as company raises guidance
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.Business - MarketWatch - October 29 -
Pfizer’s guidance bump will not heal deeper wounds
Starboard is right to take drugmaker to task for bingeing on overpriced dealsBusiness - Financial Times - October 29 -
Pfizer's Strong Quarter Bolsters CEO's Comeback Efforts
The pharmaceutical company reported its third consecutive quarter with positive results.Business - The Wall Street Journal - October 29 -
Jeff Smith, the activist picking a fight with Covid hero Pfizer
Widely feared boss of Starboard Value often befriends the corporate leaders he is targetingBusiness - Financial Times - October 25 -
How are investors preparing for the Budget?
Executives are seeking to minimise their exposure ahead of what could be the biggest tax-raising statement for a generationBusiness - Financial Times - October 29 -
Pfizer CEO defends performance after Starboard activist criticism
Drugmaker boosts full-year sales and profit forecasts after reporting better than expected earningsBusiness - Financial Times - October 29 -
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.Business - CNBC - November 7 -
Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin
Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin.Business - MarketWatch - November 7 -
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.Business - CNBC - October 29 -
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
Pfizer reported an earnings beat Tuesday morning and raised its full-year outlook, seeing strength in sales of its Covid vaccine and antiviral pill, Paxlovid.Business - CNBC - October 29